VEGFA and cancer: It also contains an additional albumin module that extends half-life in vivo.9 BI 836880 potently and selectively neutralizes VEGF and Ang-2 and showed superior antitumor activity to VEGF or Ang-2 inhibition alone in preclinical models of cancer.9